Prescribing Details
Description
COMPOSITION
Livita ® syrup: Each 5 ml of syrup contains Iron (III) Hydroxide Polymaltose Complex INN 200 mg equivalent to elemental Iron 50 mg, Thiamine Hydrochloride BP 5 mg, Riboflavin-5-Phosphate Sodium BP 2.74mg equivalent to Riboflavin 2 mg, Pyridoxine Hydrochloride BP 2 mg, Nicotinamide BP 20 mg and Zinc Sulphate Heptahydrate BP 43.97 mg equivalent to elemental Zinc 10 mg.
PHARMACOLOGY
Livita ® syrup is the preparation of Iron, Vitamin B-complex and Zinc. In the preparation, Iron is present as Iron (III) Hydroxide Polymaltose Complex, a noble Iron preparation, which contains nonionic ferric iron and Polymaltose in a stable complex. This facilitates a controlled absorption of the Iron when it comes in contact with the mucosal cell surface. Being non-ionic, Iron (III) Hydroxide Polymaltose Complex is more stable than conventional Iron form.
Livita ® syrup: Each 5 ml of syrup contains Iron (III) Hydroxide Polymaltose Complex INN 200 mg equivalent to elemental Iron 50 mg, Thiamine Hydrochloride BP 5 mg, Riboflavin-5-Phosphate Sodium BP 2.74mg equivalent to Riboflavin 2 mg, Pyridoxine Hydrochloride BP 2 mg, Nicotinamide BP 20 mg and Zinc Sulphate Heptahydrate BP 43.97 mg equivalent to elemental Zinc 10 mg.
PHARMACOLOGY
Livita ® syrup is the preparation of Iron, Vitamin B-complex and Zinc. In the preparation, Iron is present as Iron (III) Hydroxide Polymaltose Complex, a noble Iron preparation, which contains nonionic ferric iron and Polymaltose in a stable complex. This facilitates a controlled absorption of the Iron when it comes in contact with the mucosal cell surface. Being non-ionic, Iron (III) Hydroxide Polymaltose Complex is more stable than conventional Iron form.
Uses
No Data
Indications
Livita ® syrup is indicated for the treatment and prevention of Iron, B-vitamins and Zinc deficiencies.
Dosage and administration
Adults: 5 ml-10 ml (1-2 teaspoonful) 3 times daily or as recommended by the physician.
Children: 5 ml (1 teaspoonful) 3 times daily or as recommended by the physician.
Infants: 0.33 ml/kg body weight daily or as recommended by the physician.
Children: 5 ml (1 teaspoonful) 3 times daily or as recommended by the physician.
Infants: 0.33 ml/kg body weight daily or as recommended by the physician.
Use in pregnancy & lactation
No Data
Geriatric use
No Data
Precautions
Caution should be taken in the conditions where is a risk of Iron overload, such as haemochromatosis, thalassemia, haemosidereosis or haemolytic anaemia. USE IN PREGNANCY AND LACTATION: Recommended.
Side effects
Livita ® syrup is generally well tolerated. However, a few sideeffects of oral Iron preparations, including nausea, vomiting, constipation or diarrhoea may occur.
Contraindications
Livita ® syrup is contraindicated in patients with a known hypersensitivity to any of the ingredients of this product.
Drug interactions
No interactions have been observed. Since, the Iron is complex bound, ionic interaction with foodstuff components (phytates, oxalates, tannin, etc.) and concomitant administrations of medicaments (tetracyclines, antacids) are unlikely to occur.
Overdose
In case of overdose, initially epigastric pain, pain, diarrhoea and vomiting can occur and may include metabolic acidosis, convulsions and coma after apparent recovery. Should seek emergency medical attention in case of overdose. Initially an emetic should be given and then gastric lavage and general supportive measures should be employed.
Preparation
No Data
Pharmaceutical precautions
Store in a cool and dry place, away from light. Keep out of reach of children.
Presentation
No Data
Package quantitie
Livita ® 100 ml syrup:
Each pack has a bottle containing 100 ml syrup and a measuring spoon.
